Imeglimin may also be more broadly useful by encompassing potential inter‐individual and inter‐ethnic differences in disease aetiology, such as the prominent impairment of insulin secretion with an overall lesser degree of insulin resistance in East Asians compared to Caucasians.40, 41. The gene discussed is INS; the disease is Insulin resistance.